相关实验视频

Updated: May 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

单独使用PCSK9抑制剂与单独使用他类药物的降脂功效:元分析

Katie Kyan¹, Jeffrey Gornbein², Jeffrey Saver³

¹California University of Science and Medicine, Colton, CA, United States.

Frontiers in cardiovascular medicine

|March 5, 2026

概括

蛋白转化酶亚素/素9型 (PCSK9) 抑制剂显示较大LDL-C降低比他类药物. 随着专利的到期,PCSK9抑制剂即将成为有效的第一线超脂血症治疗方法.

科学领域:

心血管药理学心血管药理学
脂肪代谢障碍脂肪代谢障碍脂肪代谢障碍
药物治疗药物治疗

背景情况:

PCSK9抑制剂 (PCSK9is) 是对他类药物的补充疗法.
专利到期可能使PCSK9is成为一线代理商.
本研究将PCSK9i单疗法与高强度他单疗法进行比较.

研究的目的:

评估PCSK9i单一治疗的降脂功效.
将PCSK9i单疗与高强度他单疗作为一线药物进行比较.
评估PCSK9is作为未来一线超脂血症治疗的潜力.

主要方法:

基于PRISMA的RCT的元分析.
包括PCSK9i与对照试验和高强度他类药物与对照试验.
主要结局:LDL-C的百分比变化;次要结局:HDL-C,TC,TG,ApoB.

主要成果:

与高强度他类药物相比,PCSK9被证明具有优异的LDL-C降低 (-52.4%与-46.6%相比).
与他类药物相比,PCSK9is显示出更大的ApoB降低和HDL-C增加.
在大多数脂质参数上,PCSK9is优于阿托瓦斯塔丁,除了TG降低之外,与罗斯瓦斯塔丁相似.

结论:

单独治疗PCSK9i优于阿托瓦斯塔丁,在改善LDL-C,HDL-C,TC和ApoB方面与罗斯瓦斯塔丁相当.
对于他类药物不耐受患者来说,PCSK9是有效的二线药物.
预计PCSK9is将成为超脂血症专利到期后的有价值的第一线药物.

关键词:

这就是为什么LDL胆固醇是LDL胆固醇.PCSK9 抑制剂的使用.动脉样硬化动脉样硬化过高脂血症是什么意思降脂剂是一种降脂剂.类药物类药物类药物

更多相关视频

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...